<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">141498</id>
  <title nil="true"/>
  <common-name>Elarofiban anhydrous</common-name>
  <description>Elarofiban anhydrous is an organic compound with the formula C22H32N4O4 and an average molecular weight of 416.52 g/mol. Elarofiban anhydrous belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. Regarding its biological activity, there are two recorded protein targets for this compound. It acts as a modulator of Integrin beta-3 (ITGB3) and Integrin alpha-IIb (ITGA2B).</description>
  <cas>198958-88-2</cas>
  <pubchem-id>216230</pubchem-id>
  <chemical-formula>C22H32N4O4</chemical-formula>
  <weight>416.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-15T17:53:34Z</created-at>
  <updated-at type="dateTime">2026-08-21T23:01:59Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB21212</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>OC(=O)C[C@H](NC(=O)[C@@H]1CCCN(C1)C(=O)CCC1CCNCC1)C1=CN=CC=C1</moldb-smiles>
  <moldb-formula>C22H32N4O4</moldb-formula>
  <moldb-inchi>InChI=1S/C22H32N4O4/c27-20(6-5-16-7-10-23-11-8-16)26-12-2-4-18(15-26)22(30)25-19(13-21(28)29)17-3-1-9-24-14-17/h1,3,9,14,16,18-19,23H,2,4-8,10-13,15H2,(H,25,30)(H,28,29)/t18-,19+/m1/s1</moldb-inchi>
  <moldb-inchikey>ABNXKGFLZFSILK-MOPGFXCFSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">416.522</moldb-average-mass>
  <moldb-mono-mass type="decimal">416.242355526</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-2.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM137391</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(3S)-3-[[(3R)-1-(3-piperidin-4-ylpropanoyl)piperidine-3-carbonyl]amino]-3-pyridin-3-ylpropanoic acid</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic acids and derivatives</superklass>
  <klass>Carboxylic acids and derivatives</klass>
  <subklass>Amino acids, peptides, and analogues</subklass>
  <paper-count type="integer">2</paper-count>
  <sync-id>CED0054623</sync-id>
  <structure-inchikey>ABNXKGFLZFSILK-MOPGFXCFSA-N</structure-inchikey>
  <structure-fingerprint>60000004000000000000800200002400000000000000002000000000000000000000000010004000000000000000402004000000000004020000000000000000200000000000000000000000000002000020020002004000000000001000000000000000810000008000000000000000000000020100000000024000080040100800100000000000800000204000040080000010000000000000000000000000002000080004000000000400080000000000000400000000008000000008000900000008000420001000000000000000000000000000000000400200000000000000080000000000002040000000000400000000000000000000004000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAeAAAAIAAAAIABCABoAAAAAwEBBgAoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:52:14Z</structure-indexed-at>
</compound>
